Clinical Trials Directory

Trials / Completed

CompletedNCT05244044

Pulmonary Rehabilitation for Long COVID (Post COVID-19 Condition)

Changes in Functional Exercise Capacity After PUlmonary REhabilitation in Primary Care: a Randomized, Controlled, Multicenter, Pragmatic Trial in 134 Patients With Long COVID (PuRe-COVID)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
University Hospital, Antwerp · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In the PuRe COVID study (a randomized, controlled, multicenter, pragmatic trial) the investigators aim to assess the effect of a pulmonary rehabilitation program in primary care on exercise capacity (6MWT) and daily life physical activity in patients with long COVID. 134 patients with long COVID, defined by self-reported persistent COVID related symptoms ≥6 weeks after COVID-19 infection and a positive symptom score (CAT score ≥10 or mMRC score ≥2 or CIS-fatigue ≥36 or PCFS score of ≥2), will be recruited and divided into an intervention group or a control group. The intervention group will get twelve weeks of primary care pulmonary rehabilitation (PR) including coaching by primary care physiotherapists. The control group consists of usual care, which does not include a pulmonary rehabilitation program. This study will help determine whether the type of symptoms or affected body system can impact recovery form long covid during rehabilitation and after follow-up. The investigators will analyze determinants and risk factors that characterize non-responders and non-adherers to better understand which patients with long COVID benefit from rehabilitation.

Conditions

Interventions

TypeNameDescription
OTHERPulmonary rehabilitation in primary carePulmonary rehabilitation consists breathing exercises, exercise capacity, muscle strength and change towards an active lifestyle.

Timeline

Start date
2022-04-19
Primary completion
2023-12-18
Completion
2024-02-29
First posted
2022-02-17
Last updated
2024-10-01

Locations

2 sites across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05244044. Inclusion in this directory is not an endorsement.